Literature DB >> 33608437

Wipe-sampling procedure optimisation for the determination of 23 antineoplastic drugs used in the hospital pharmacy.

Nicolas Guichard1,2,3, Julien Boccard2, Serge Rudaz2, Pascal Bonnabry2,3, Sandrine Fleury Souverain4,2,3.   

Abstract

PURPOSE: Optimise a wipe sampling procedure to evaluate the surface contamination for 23 antineoplastic drugs used in the hospital pharmacy.
METHODS: The influence of various parameters (ie, sampling device, sampling solution, desorption modes) was evaluated using a validated liquid chromatography-mass spectrometry (LC-MS/MS) method able to quantify 23 antineoplastic drugs widely used in the hospital pharmacy: 5-fluorouracil, busulfan, cyclophosphamide, cytarabine, dacarbazine, daunorubicin, docetaxel, doxorubicin, epirubicin, etoposide, etoposide phosphate, fludarabine phosphate, ganciclovir, gemcitabine, idarubicin, ifosfamide, irinotecan, methotrexate, paclitaxel, pemetrexed, raltitrexed, topotecan and vincristine. Best conditions were tested with real samples from a hospital pharmacy chemotherapy compounding unit.
RESULTS: Polyester swabs (TX714 and TX716) gave satisfactory results for the desorption step for all compounds with mean recoveries of 90% and 95%, respectively. For the wiping step, higher recoveries were obtained using TX716 and isopropanol 75% as wiping solution. As anticipated, most intense contaminations were found close to the chemotherapy production site, on surfaces the most frequently in contact with operators' hands.
CONCLUSION: Wipe sampling method was successfully developed and applied to real samples to determine surface contamination with 23 antineoplastic agents in trace amounts. © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cytotoxics; surface contamination; wipe sampling

Mesh:

Substances:

Year:  2019        PMID: 33608437      PMCID: PMC7907690          DOI: 10.1136/ejhpharm-2019-001983

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  11 in total

1.  Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.

Authors:  Susanne Nussbaumer; Laurent Geiser; Farshid Sadeghipour; Denis Hochstrasser; Pascal Bonnabry; Jean-Luc Veuthey; Sandrine Fleury-Souverain
Journal:  Anal Bioanal Chem       Date:  2011-06-24       Impact factor: 4.142

Review 2.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

3.  ASHP Guidelines on Handling Hazardous Drugs.

Authors:  Luci A Power; Joseph W Coyne
Journal:  Am J Health Syst Pharm       Date:  2018-10-16       Impact factor: 2.637

4.  A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments.

Authors:  Stefano Dugheri; Alessandro Bonari; Ilenia Pompilio; Pierpaolo Boccalon; Nicola Mucci; Giulio Arcangeli
Journal:  Arh Hig Rada Toksikol       Date:  2018-09-01       Impact factor: 1.948

5.  Computer-assisted UHPLC-MS method development and optimization for the determination of 24 antineoplastic drugs used in hospital pharmacy.

Authors:  Nicolas Guichard; Szabolcs Fekete; Davy Guillarme; Pascal Bonnabry; Sandrine Fleury-Souverain
Journal:  J Pharm Biomed Anal       Date:  2018-11-06       Impact factor: 3.935

6.  Permeability of gloves to selected chemotherapeutic agents after treatment with alcohol or isopropyl alcohol.

Authors:  Arnaud Capron; Jennifer Destree; Philippe Jacobs; Pierre Wallemacq
Journal:  Am J Health Syst Pharm       Date:  2012-10-01       Impact factor: 2.637

Review 7.  A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs.

Authors:  Thomas Kibby
Journal:  J Occup Environ Hyg       Date:  2017-03       Impact factor: 2.155

8.  Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surface Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry.

Authors:  Manuel Colombo; Matthew Jeronimo; George Astrakianakis; Chirag Apte; Chun-Yip Hon
Journal:  Ann Work Expo Health       Date:  2017-10-01       Impact factor: 2.179

9.  Hazardous Drugs: Handling in Health Care Settings.

Authors:  Susan A Randolph
Journal:  Workplace Health Saf       Date:  2018-03-22       Impact factor: 1.413

Review 10.  Preventing occupational exposures to antineoplastic drugs in health care settings.

Authors:  Thomas H Connor; Melissa A McDiarmid
Journal:  CA Cancer J Clin       Date:  2006 Nov-Dec       Impact factor: 508.702

View more
  2 in total

1.  Development and Proof of Concept of an Audit Toolkit for the Safe Handling of Cytotoxic Drugs in Low- and Middle-Income Countries.

Authors:  Sandrine von Grünigen; Ludivine Falaschi; Nicolas Guichard; Sandrine Fleury-Souverain; Antoine Geissbühler; Pascal Bonnabry
Journal:  JCO Glob Oncol       Date:  2021-09

Review 2.  Cytostatics in Indoor Environment: An Update of Analytical Methods.

Authors:  M Francisca Portilha-Cunha; A Alves; Mónica S F Santos
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.